Answers are grounded in this paper and cite their sources.
Here, among three nominated TLRs for predicting UC patients, TLR-7 was potentially selected according to the significant difference in mRNA expression in flareup UC patients and control donors. TLR-7 could be used as a novel non-invasive biomarker for monitoring UC patients in the active course of the disease.
No takes yet. Share an insight, caveat, or question.
Asadzadeh‐Aghdaei et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: